NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

NEUREN PHARMACEUTICALS LIMITED (NEU)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of NEU: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Link Market Services Melbourne
Tower 4, 727 Collins Street Docklands VIC 3008
Tel : +61 3 9615 9800 or 61 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

ISIN: NZNEUE0001S8
Address: P.O Box 9923, New Market, AUCKLAND, NEW ZEALAND, 1001
Tel:  +64 9 3700 200Fax: +64 9 361 7981

Date first listed: 03/02/2005

Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Biopharmaceutical company with a focus on neuroprotection and metabolism.

News & Events

Expand this box to read and print

we understand that on or about this date the company consolidated its shares 1 for 20

29/11/2017

shares reinstated to quotation

18/11/2009

the securities of Neuren Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to capital raising initiatives

16/11/2009

the suspension of trading in the securities of Neuren Pharmaceuticals Limited (the "Company") will be lifted following the completion of its capital raising

06/08/2008

company requests an extension to the voluntary suspension of the Company's securities from official quotation pending an announcement in relation to a proposed capital raising by Neuren - Neuren proposes that the voluntary suspension be lifted at the earlier of the announcement or the commencement of trading on 6 August 2008

04/08/2008

shares suspended from quotation pending an announcement about a capital raising

31/07/2008

shares reinstated to quotation following receipt of an announcement providing details of the Company's capital raising

02/12/2005

shares suspended from quotation pending an announcement about a capital raising

01/12/2005

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    11/06/2024Joe Basile5,000$19.490$97,450
    13/09/2023Joe Basile5,000$11.990$59,950
    14/06/2023Trevor Scott-1,175,000$13.000$15,275,000
    18/10/2021Dianne Angus30,000$1.980$59,400
    24/06/2021Patrick Davies43,694$1.400$61,172

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Patrick DaviesNon Exec Chairman04/07/2018
    Jon PilcherManaging Director, CEO19/08/2013
    Lauren FrazerCFO, Company Secretary01/08/2020
    Dianne AngusIndependent Director03/07/2018
    Joe BasileIndependent Director02/03/2023
    Trevor ScottNon Exec Director05/03/2002
    Jenny HarryNon Exec Director04/07/2018

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Richard TreagusExecutive Chairman31/01/201327/05/2020
    Larry GlassExecutive Director, CEO02/09/201331/12/2018
    Bruce HancoxNon Exec Director08/03/201231/12/2017
    Rob TurnbullCFO30/08/2013
    John HoladayNon Exec Director25/11/200930/08/2013
    Douglas WilsonNon Exec Director17/06/200420/05/2013
    Robin CongreveDirector17/12/200120/05/2013
    Graeme HowieNon Exec Director04/02/200531/05/2012

    Date of first appointment, title may have changed.